Aurélie Cabrespine
Aurélie Cabrespine
Unknown affiliation
Verified email at
Cited by
Cited by
Enteral versus parenteral nutritional support in allogeneic haematopoietic stem-cell transplantation
R Guièze, R Lemal, A Cabrespine, E Hermet, O Tournilhac, C Combal, ...
Clinical nutrition 33 (3), 533-538, 2014
Prevalence of malnutrition in adult patients previously treated with allogeneic hematopoietic stem-cell transplantation
T Brotelle, R Lemal, A Cabrespine, C Combal, E Hermet, A Ravinet, ...
Clinical Nutrition 37 (2), 739-745, 2018
Could enteral nutrition improve the outcome of patients with haematological malignancies undergoing allogeneic haematopoietic stem cell transplantation? A study protocol for a …
R Lemal, A Cabrespine, B Pereira, C Combal, A Ravinet, E Hermet, ...
Trials 16, 1-9, 2015
Impact of uncontrolled freezing and long-term storage of peripheral blood stem cells at− 80 C on haematopoietic recovery after autologous transplantation. Report from two centres
G Detry, L Calvet, N Straetmans, A Cabrespine, C Ravoet, JO Bay, ...
Bone Marrow Transplantation 49 (6), 780-785, 2014
Circulating chromogranin a and hormone refractory prostate cancer chemotherapy
A Cabrespine, L Guy, F Gachon, H Curé, P Chollet, JO Bay
The Journal of urology 175 (4), 1347-1352, 2006
Prevalence of chemotherapy-induced peripheral neuropathy in multiple myeloma patients and its impact on quality of life: a single center cross-sectional study
M Selvy, N Kerckhove, B Pereira, F Barreau, D Nguyen, J Busserolles, ...
Frontiers in Pharmacology 12, 637593, 2021
Autologous hematopoietic stem cell transplantation in elderly patients (≥ 70 years) with non-Hodgkin's lymphoma: A French Society of Bone Marrow Transplantation and Cellular …
E Hermet, A Cabrespine, R Guieze, A Garnier, A Tempescul, P Lenain, ...
Journal of geriatric oncology 6 (5), 346-352, 2015
Randomized phase II study comparing paclitaxel and carboplatin versus mitoxantrone in patients with hormone-refractory prostate cancer
A Cabrespine, L Guy, E Khenifar, H Curé, J Fleury, F Penault-Llorca, ...
Urology 67 (2), 354-359, 2006
Possible benefits of curcumin regimen in combination with taxane chemotherapy for hormone-refractory prostate cancer treatment
A Cabrespine-Faugeras, M Bayet-Robert, JO Bay, P Chollet, ...
Nutrition and cancer 62 (2), 148-153, 2010
Hematologic, immunologic reconstitution, and outcome of 342 autologous peripheral blood stem cell transplantations after cryopreservation in a− 80 C mechanical freezer and …
L Calvet, A Cabrespine, N Boiret‐Dupré, E Merlin, C Paillard, M Berger, ...
Transfusion 53 (3), 570-578, 2013
In vitro assessment of cytotoxic agent combinations for hormone-refractory prostate cancer treatment
A Cabrespine, JO Bay, C Barthomeuf, H Curé, P Chollet, E Debiton
Anti-Cancer Drugs 16 (4), 417-422, 2005
Retrospective study of allogeneic haematopoietic stem-cell transplantation for myelofibrosis
S Lissandre, JO Bay, JY Cahn, R Porcher, V Cacheux, A Cabrespine, ...
Bone Marrow Transplantation 46 (4), 557-561, 2011
Molecular mechanisms involved in hormone resistance of prostate cancer
A Cabrespine, L Guy, P Chollet, É Debiton, JO Bay
Bulletin du Cancer 91 (10), 747-757, 2004
Impact of Thymoglobulin by Stem Cell Source (Peripheral Blood Stem Cell or Bone Marrow) After Myeloablative Stem Cell Transplantation From HLA 10/10-Matched Unrelated Donors: A …
A Ravinet, A Cabrespine, G Socié, N Milpied, IY Agha, S Nguyen, ...
Transplantation 100 (8), 1732-1739, 2016
Allogeneic hematopoietic stem cell transplantation in ovarian cancer—the EBMT experience
JO Bay, A Cabrespine‐Faugeras, R Tabrizi, D Blaise, P Viens, ...
International journal of cancer 127 (6), 1446-1452, 2010
Prognostic impact of JAK2V617F mutation in myelodysplatic syndromes: A matched case control study
B de Renzis, V Mansat-De Mas, E Wattel, O Beyne-Rauzy, L Knoops, ...
Leukemia research reports 2 (2), 64-66, 2013
Interleukin-6 implication in prostate cancer
A Cabrespine, JO Bay, P Verrelle, L Morel
Bulletin du Cancer 94 (4), 29-34, 2007
Impact of ATG dose on the outcome of patients undergoing reduced intensity conditioning followed by allogeneic hematopoietic stem cell transplantation for hematological …
J Cornillon, M Balsat, A Cabrespine, E Tavernier-Tardy, E Hermet, ...
Acta Haematologica 136 (4), 193-200, 2016
Hematopoietic Stem Cell Transplantation (HSCT) in Waldenström Macroglobulinemia (Wm), Update of the French Experience in 54 Cases.
N Dhedin, R Tabrizi, PE Bulabois, S Le Gouill, V Coiteux, C Dartigeas, ...
Blood, The Journal of the American Society of Hematology 110 (11), 3015-3015, 2007
Efficacy of minimal residual disease driven immune-intervention after allogeneic hematopoietic stem cell transplantation for high-risk chronic lymphocytic leukemia: results of …
O Tournilhac, M Le Garff-Tavernier, SN Quoc, E Forcade, P Chevallier, ...
haematologica 106 (7), 1867, 2021
The system can't perform the operation now. Try again later.
Articles 1–20